Introduction
While the two major types of cells in the brain are known to be glia and neuron, the true ratio of glia to neurons in the brain remains a mystery. One of recent studies using efficient cell counting method provides compelling evidence for 1:1 ratio on four whole human brains 1 . The same study also reveals that the ratio of glia to neurons in the brain varies from one region to another, sometimes dramatically, e.g., 3.76:1 in the cerebral cortex versus 1:4.3 in the cerebellum 1,2 . However, other scientists have argued that more rigorous studies are needed in which just about every known or unknown marker for both neurons and glia is used to capture as many of the different cell types as possible.
Here we report a study that applies UNsupervised DecOnvolution version 2 (UNDO2.0) software tool 3 , the spin-off from the Convex Analysis of Mixtures (CAM) framework for deconvolving mixtures of more than two subtypes 4 , to the gene expression and DNA methylation data acquired from heterogeneous brain tissues. UNDO2.0 can automatically detect cell-specific markers located on the scatter radii of mixed gene expressions, estimate cellular proportions in each sample, and deconvolve mixed expressions into cell-specific expression profiles. The in-silico analysis uncovers many novel marker genes and provides the molecularly-defined 2.2:1 ratio of glia to neurons in the brain.
An R package of UNDO2.0 is available at http://bioconductor.org/packages/UNDO.
An R package of CAM is available at http://bioconductor.org/packages/CAMTHC.
Results

Re-validation of UNDO2.0 on benchmark datasets
We first test UNDO2.0 on the gene expression data acquired from Rat neuronastrocyte mixtures (GSE19380 5 ). We apply UNDO2.0 to the 3 mixtures of neuron and astrocyte, samples 17, 19, 21. Experimental result shows accurate estimate of both cellular proportions (correlation coefficient of 0.997~0.998 between known proportions and the estimates by UNDO2.0) and cell-specific expression profiles (correlation coefficient of 0.984~0.988 between the UNDO2.0 estimates and pure neuron/glia expressions).
We then test UNDO2.0 on the DNA methylation data acquired from post mortem frontal cortex (GSE41826 6,7 ). The platform is Illumina HumanMethylation450 BeadChip.
There are 480,492 probes in total. We apply UNDO2.0 to the 9 reconstituted mixtures of FACS-purified neuron and glia with neuron proportions varying from 10% to 90%. The experimental results are summarized in Figure 1 . Huntington's disease is neuronal death and glial proliferation of caudate nucleus 5 . We apply UNDO2.0 to these three sample groups separately, and estimate both the neuron/glia proportions and neuron/glia-specific expression profiles. The experimental results are consistent with what previously reported by supervised deconvolution method on the same dataset 5 , as summarized in Table 2 .
Specifically, in Huntington's disease groups, both mean expression levels and proportions in the neurons decrease, while the opposite changes are observed in glial cells. To illustrate the invalidity of the common assumption that the expression signatures of cell-type specific markers are invariant across phenotypes, made necessarily by most supervised deconvolution methods 5 , we also check the mean expression levels of cellspecific marker genes across the three phenotypic groups, and observe significance changes in the marker gene expressions associated with both neurons (5 genes) and glia (9 genes), shown in Figure 3 .
UNDO2.0 Analysis on gene expression data of different brain regions
We first apply UNDO2.0 to the gene expression data of 129 samples acquired from cerebellum (CB). The deconvolution results indicate that the overall neuron proportion is about 70% and non-neuron proportion about 30%, consistent with what previously reported 1,2 . We then apply UNDO2.0 to the gene expression data of 129 samples acquired from parietal cortex (PC). The neuro/glia marker genes blindly detected by UNDO2.0 are geometrically close to (overlap), in the scatter simplex, the marker genes given by literatures 5 , as shown in Figure 4 . More interestingly, the deconvolution also reveals that the overall glia to neuron ratios are different between CB and PC, indicating that neuron/glia distributions may be region-dependent.
We then apply UNDO2.0 to the paired 258 samples all together, and detect the two dominant yet most differential neuron cell types that are concordantly associated with CB versus PC brain regions. Strikingly, our experiment detects many region-specific neuron markers that are exclusively enriched in CB or PC neurons, shown in Figure 5 , molecularly defining two region-dependent neuron subpopulations.
UNDO2.0 Analysis on methylation data in human brain cerebellum region
We apply UNDO2.0 to the methylation data of 130 CB samples and detect two cell types with relative proportions of 30% and 70%, respectively. After a sample-wise comparison on the relative proportion vectors (non-neuron : neuron), estimated using methylation data and that of gene expression data acquired from the same regional samples, we observed a high correlation coefficient of 0.948 (see Figure 6 ) that indicates that the two cellular subpopulations deconvolved from methylation data correspond to neuron and nonneuron cells. While correlation coefficient is a classic concept, its calculation in comparing the estimates by two different methods needs special care. If the cellular proportions associated with each sample, in a population, are largely random over the entire space of 'proportion vectors', then, the correction coefficient between two estimates can be calculated over either one individual component or all components of the proportion vector. In contrast, if such cellular proportions are cluster-structured with moderate randomness', e.g., the cellular proportions of neuron and glia cells follow an average ratio, then correlation coefficient between two estimates should be calculated using all components of the proportion vector, and within-cluster high correlation may not be expected.
Discussion
Methods
See reference 3 .
Availability of UNDO2.0 software
The R package of UNDO2.0 is available for academic and non-commercial use at:
http://www.bioconductor.org/packages/release/bioc/html/UNDO2.0.html
ADDITIONAL INFORMATION
Supplementary information accompanies this paper at http://www.
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